A new paradigm for improved co-ordination and efficacy of European biomedical research: taking diabetes as a model P. A. HalbanA. J. M. BoultonU. Smith Commentary 13 December 2012 Pages: 439 - 443
Towards microRNA-based therapeutics for diabetic nephropathy M. L. AlvarezJ. K. DiStefano Review 08 November 2012 Pages: 444 - 456
Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis F. HeX. XiaF. X. Huang Meta-analysis 12 December 2012 Pages: 457 - 466
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial E. BosiG. Baxon behalf of the FREMS European Trial Study Group Article Open access 13 December 2012 Pages: 467 - 475
Incidence of diabetes among postmenopausal breast cancer survivors L. L. LipscombeW. W. ChanP. A. Rochon Article 13 December 2012 Pages: 476 - 483
Serum potassium is associated with prediabetes and newly diagnosed diabetes in hypertensive adults from the general population: The KORA F4-Study C. MeisingerD. StöcklW. Rathmann Article 25 November 2012 Pages: 484 - 491
Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes A. BonnefondL. YengoM. Vaxillaire Short Communication 06 December 2012 Pages: 492 - 496
Autonomous and self-sustained circadian oscillators displayed in human islet cells P. PulimenoT. MannicC. Dibner Article Open access 15 December 2012 Pages: 497 - 507
The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation Y. J. ParkZ. AoL. Marzban Article 23 December 2012 Pages: 508 - 519
Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells B. M. TanN. W. ZammitS. T. Grey Article 20 December 2012 Pages: 520 - 532
Hydrogen sulfide-induced inhibition of L-type Ca2+ channels and insulin secretion in mouse pancreatic beta cells G. TangL. ZhangR. Wang Article 30 December 2012 Pages: 533 - 541
Identification and analysis of murine pancreatic islet enhancers B. R. TennantA. G. RobertsonB. G. Hoffman Article 14 December 2012 Pages: 542 - 552
Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin–angiotensin system in mice Q. ChengB. J. BoucherP. S. Leung Article 19 December 2012 Pages: 553 - 562
HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus R. StrolloP. RizzoA. Nissim Article 19 November 2012 Pages: 563 - 572
Rotavirus acceleration of murine type 1 diabetes is associated with a T helper 1-dependent specific serum antibody response and virus effects in regional lymph nodes J. A. PaneN. L. WebsterB. S. Coulson Article 14 December 2012 Pages: 573 - 582
Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetes R. E. van GenugtenE. H. SernéM. Diamant Article 24 November 2012 Pages: 583 - 587
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? A. M. ArafatP. KaczmarekM. Z. Strowski Article 22 December 2012 Pages: 588 - 597
Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes E. PanzhinskiyY. HuaS. Nair Article 24 November 2012 Pages: 598 - 607
AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle R. S. Lee-YoungJ. S. BonnerD. H. Wasserman Article 08 December 2012 Pages: 608 - 617
In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats R. A. M. JonkersL. J. C. van LoonJ. J. Prompers Article Open access 13 December 2012 Pages: 618 - 626
Amylin-induced downregulation of hippocampal neurogenesis is attenuated by leptin in a STAT3/AMPK/ERK-dependent manner in mice H.-S. MoonF. DincerC. S. Mantzoros Article 09 December 2012 Pages: 627 - 634
Adenovirus-mediated overexpression of Tcfe3 ameliorates hyperglycaemia in a mouse model of diabetes by upregulating glucokinase in the liver M. Y. KimS. H. JoY. H. Ahn Article 27 December 2012 Pages: 635 - 643
Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model S. HazraY. P. R. JarajapuM. B. Grant Article 29 November 2012 Pages: 644 - 653
The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes S. C. ElmsH. A. ToqueR. B. Caldwell Article 12 December 2012 Pages: 654 - 662
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes X. ZhongA. C. K. ChungH. Y. Lan Article 05 January 2013 Pages: 663 - 674
Attenuation of Armanni–Ebstein lesions in a rat model of diabetes by a new anti-fibrotic, anti-inflammatory agent, FT011 X. LauY. ZhangD. I. Stapleton Article 16 December 2012 Pages: 675 - 679
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) S. E. InzucchiR. M. BergenstalD. R. Matthews Erratum 16 December 2012 Pages: 680 - 680
Erratum to: Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice M. Y. KimJ. H. LimC. W. Park Erratum 09 December 2012 Pages: 681 - 681